A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
about
A novel cancer vaccine strategy with combined IL-18 and HSV-TK gene therapy driven by the hTERT promoter in a murine colorectal cancer model.Gene therapy for the treatment of oral squamous cell carcinoma.Do there exist synergistic antitumor effects by coexpression of herpes simplex virus thymidine kinase with cytokine genes on human gastric cancer cell line SGC7901?Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational controlNovel gene-directed enzyme prodrug therapies against prostate cancer.Fas-mediated apoptotic signaling in the mouse brain following reovirus infectionGene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12.Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase and cytokine genes expressed in gastric carcinoma cell line SGC7901.Adenovirus-mediated tumor-specific combined gene therapy using Herpes simplex virus thymidine/ganciclovir system and murine interleukin-12 induces effective antitumor activity against medullary thyroid carcinoma.Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expression.Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents.Targeted gene therapy of the HSV-TK/hIL-12 fusion gene controlled by the hSLPI gene promoter of human non-small cell lung cancer in vitro.
P2860
Q34120400-CFDF1F27-63C5-4D1E-8653-E8A8DD099DDBQ35036732-EB76CE93-10BF-4930-AD2E-9FB5FFE18732Q36474568-0BFC6455-3E21-48F8-9C26-06EE7A9FA186Q36498617-FB1FA5BA-F97A-44A2-AB42-71DACD69FA3EQ36543076-48431403-49A8-42F3-88F9-E83610FA6AE8Q37204618-CF9CDC1A-C042-4B0D-AE83-B471738DB7CEQ38703318-382CB4BA-DA21-4789-B7D4-702BDDE987D8Q40541147-3091EF57-C1E2-420F-ADA0-948BB3323A01Q40606271-B68AB7A9-C868-4386-A697-CF4C9BFD420FQ40657886-9FD24CF9-EB17-4FE5-A195-E258FB9534B0Q45883538-7DF876E3-B367-4B5E-A7EE-E67D8F450191Q54112053-5FE2024E-0F75-40AE-9CAE-F4B0FA63DBD3
P2860
A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
A novel bystander effect invol ...... experimental prostate cancer.
@en
A novel bystander effect invol ...... experimental prostate cancer.
@nl
type
label
A novel bystander effect invol ...... experimental prostate cancer.
@en
A novel bystander effect invol ...... experimental prostate cancer.
@nl
prefLabel
A novel bystander effect invol ...... experimental prostate cancer.
@en
A novel bystander effect invol ...... experimental prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
A novel bystander effect invol ...... experimental prostate cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3301669
P577
2002-04-01T00:00:00Z
P5875
P6179
1026590378